This unit has a wide and diverse client base and covers both Private and Institutional sectors. Private sector deals with private pharmacies and private hospitals whereas; Institutional sector deals with Ministries, Charitable Societies, and Government subsidiaries etc.
This unit has a wide and diverse client base and covers both Private and Institutional sectors. Private sector deals with private pharmacies and private hospitals whereas; Institutional sector deals with Ministries, Charitable Societies, and Government subsidiaries etc.
This unit aim is to deliver the most advanced technology and devices to accelerate diagnostic and therapeutic processes and thus to reduce the period spent by the patient in the hospital, intensive care ward or operating theater, as well as reducing treatment costs by adequate structure of the therapy, optimal patient monitoring and avoiding complications which in turn will save more lives.
The Autoimmune Unit was officially established in April 2018, with the aim to provide cutting-edge products of top global pharmaceutical companies to improve the health and quality of life of patients suffering from autoimmune disease.
The Autoimmune Unit was officially established in April 2018, with the aim to provide cutting-edge products of top global pharmaceutical companies to improve the health and quality of life of patients suffering from autoimmune disease.
Our mission is to improve the quality of life for people through our selection of strategic products.
Our mission is to improve the quality of life for people through our selection of strategic products.
This unit focus on providing meaningful advances to patients who live with serious and life-threating rare genetic diseases.
This unit focus on providing meaningful advances to patients who live with serious and life-threating rare genetic diseases.
This unit is specialized in delivering the most advanced medical treatment for cancer types patients, providing HCP’s with cutting-edge cancer treatment products (chemotherapy, immunotherapy, targeted therapy, and stem-cell transplant supportive therapy).
This unit is specialized in delivering the most advanced medical treatment for cancer types patients, providing HCP’s with cutting-edge cancer treatment products (chemotherapy, immunotherapy, targeted therapy, and stem-cell transplant supportive therapy).
People living with hematological diseases should have the right to pursue the opportunities they desire, and to live lives beyond their diseases.
People living with hematological diseases should have the right to pursue the opportunities they desire, and to live lives beyond their diseases.
Represents international companies for products to improve animal health and protein production and public-health insecticides.
Bader Sultan & Bros. Co. W.L.L. (BSBC), part of Sultan Ben Essa Sons holding company, surpassed its golden jubilee in 2010 supremely confident of its role.